Shai's mailing address filed with the SEC is 3 SMADAR ST., , SAVION, L3, 56546.
Over the last 17 years, insiders at Pluri Inc have traded over 7,081,854$ worth of Pluri Inc stock and bought 2,345,914 units worth 14,327,834$ . The most active insiders traders include Wolf Capital Limited Part...、Zami Aberman、Israel Ben Yoram. On average, Pluri Inc executives and independent directors trade stock every 64 days with the average trade being worth of 54,123$. The most recent stock trade was executed by Zami Aberman on 10 February 2022, trading 80,616 units of PSTI stock currently worth 145,109$.
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late-stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off- the-shelf, without tissue matching. Pluristem has a strong intellectual property position; a
Pluri Inc executives and other stock owners filed with the SEC include: